Literature DB >> 3165599

Effect of histamine and prostaglandin E2 on the microcirculation in the skin.

E I Harper1, J S Beck, V A Spence, R A Brown.   

Abstract

The response of the cutaneous microvasculature to two vasoactive mediators, histamine and prostaglandin E2, was measured by laser Doppler velocimetry. Four concentrations of histamine (1.01 to 65.1 X 10(-5) M, in fourfold dilutions) were injected intradermally into the forearms of six healthy subjects: Prostaglandin E2 (1.77 to 114.0 X 10(-8) M, also in fourfold dilutions) was injected several weeks later. The blood flow at the injection site was measured by laser Doppler velocimetry at five minute intervals until the response resolved. Both mediators produced hyperaemia with markedly accelerated cutaneous blood flow. Analysis of the dose response data showed that, for a given mediator, the differences in responses between subjects were not substantial and, in particular, that the kinetics of the decay of hyperaemia did not vary significantly between subjects. The response to histamine differed from that to Prostaglandin E2 in terms of time to maximum response, duration of maximum response and coefficient of decay.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3165599     DOI: 10.1007/bf01968086

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  12 in total

1.  Enzymatic histamine degradation by human skin.

Authors:  D Francis; M W Greaves; S Yamamoto
Journal:  Br J Pharmacol       Date:  1977-08       Impact factor: 8.739

2.  Quantification of weal reactions with laser Doppler flowmetry. Comparative blood flow measurements of the oedematous centre and the perilesional flare of skin-prick histamine weals.

Authors:  J Serup; B Staberg
Journal:  Allergy       Date:  1985-05       Impact factor: 13.146

3.  Patterns of blood flow in the microcirculation of the skin during the course of the tuberculin reaction in normal human subjects.

Authors:  J Swanson Beck; V A Spence
Journal:  Immunology       Date:  1986-06       Impact factor: 7.397

4.  Prostaglandin on cutaneous vasculature.

Authors:  L M Solomon; L Juhlin; M B Kirschenbaum
Journal:  J Invest Dermatol       Date:  1968-10       Impact factor: 8.551

5.  Spatial and temporal variations in human skin blood flow.

Authors:  T Tenland; E G Salerud; G E Nilsson; P A Oberg
Journal:  Int J Microcirc Clin Exp       Date:  1983

6.  Evaluation of a laser Doppler flowmeter for measurement of tissue blood flow.

Authors:  G E Nilsson; T Tenland; P A Oberg
Journal:  IEEE Trans Biomed Eng       Date:  1980-10       Impact factor: 4.538

7.  Prostaglandins: their disappearance from and release into the circulation.

Authors:  S H Ferreira; J R Vane
Journal:  Nature       Date:  1967-12-02       Impact factor: 49.962

8.  On the mechanism of vascular leakage caused by histaminetype mediators. A microscopic study in vivo.

Authors:  G Majno; V Gilmore; M Leventhal
Journal:  Circ Res       Date:  1967-12       Impact factor: 17.367

9.  Prostaglandin E2, prostaglandin I2 and the vascular changes of inflammation.

Authors:  T J Williams
Journal:  Br J Pharmacol       Date:  1979-03       Impact factor: 8.739

10.  Studies on inflammation. II. The site of action of histamine and serotonin along the vascular tree: a topographic study.

Authors:  G MAJNO; G E PALADE; G I SCHOEFL
Journal:  J Biophys Biochem Cytol       Date:  1961-12
View more
  3 in total

1.  Dynamic thermographic imaging method for quantifying dermal perfusion: potential and limitations.

Authors:  S B Wilson; V A Spence
Journal:  Med Biol Eng Comput       Date:  1989-09       Impact factor: 2.602

2.  The influence of histamine and PGE2-induced hyperaemia and oedema on respiratory metabolism in normal human forearm skin.

Authors:  F M Carnochan; N C Abbot; J S Beck; V A Spence; P B James
Journal:  Agents Actions       Date:  1990-03

3.  Effect of topically applied local anaesthesia on histamine flare in man measured by laser Doppler velocimetry.

Authors:  E I Harper; J S Beck; V A Spence
Journal:  Agents Actions       Date:  1989-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.